The PaO₂/FiO₂ ratio, commonly known as the P/F ratio, is a widely used measure of pulmonary oxygenation that assesses the efficiency of oxygen transfer from the alveoli into the arterial circulation. It is one of the most important physiological indices used in respiratory and critical care medicine and provides an objective assessment of gas exchange that is largely independent of the concentration of inspired oxygen being administered.
The ratio is calculated by dividing the arterial partial pressure of oxygen (PaO₂), obtained from an arterial blood gas (ABG) sample, by the fraction of inspired oxygen (FiO₂) delivered to the patient. By accounting for the level of supplemental oxygen being administered, the P/F ratio offers a standardised method of evaluating oxygenation across a wide range of clinical settings.
The P/F ratio is routinely used in emergency medicine, respiratory medicine, anaesthesia, perioperative care, and intensive care to assess hypoxaemia, monitor disease progression, evaluate response to treatment, and support decisions regarding escalation of respiratory support.
Calculation of the P/F Ratio
The P/F ratio is calculated using the following equation:
PaO₂ ÷ FiO₂ = P/F Ratio
Where:
- PaO₂ is the arterial partial pressure of oxygen measured by arterial blood gas analysis.
- FiO₂ is the fraction of inspired oxygen expressed as a decimal (for example, room air = 0.21, 40% oxygen = 0.40, and 100% oxygen = 1.00).
Because FiO₂ is incorporated into the calculation, the P/F ratio provides a more meaningful assessment of oxygenation than arterial oxygen tension alone.
Clinical Significance
The P/F ratio is an objective indicator of pulmonary gas exchange efficiency. A lower ratio reflects impaired oxygen transfer across the alveolar-capillary membrane and indicates increasing severity of hypoxaemia.
Reduced P/F ratios may occur in a variety of acute and chronic respiratory conditions, including:
- Acute respiratory distress syndrome (ARDS)
- Pneumonia
- Pulmonary oedema
- Pulmonary embolism
- Severe asthma
- Chronic obstructive pulmonary disease (COPD)
- COVID-19 pneumonitis
- Interstitial lung disease
- Aspiration pneumonitis
- Other causes of acute respiratory failure
Serial measurements are frequently more informative than isolated values and are commonly used to monitor disease progression and response to interventions such as supplemental oxygen, non-invasive ventilation, prone positioning, or invasive mechanical ventilation.
Role in Acute Respiratory Distress Syndrome (ARDS)
One of the most important clinical applications of the P/F ratio is in the diagnosis and severity classification of acute respiratory distress syndrome (ARDS).
The Berlin Definition of ARDS classifies disease severity according to the PaO₂/FiO₂ ratio in patients receiving a minimum level of positive end-expiratory pressure (PEEP):
| ARDS Severity | PaO₂/FiO₂ Ratio |
|---|---|
| Mild | 201–300 mmHg |
| Moderate | 101–200 mmHg |
| Severe | ≤100 mmHg |
These categories are interpreted alongside additional diagnostic criteria, including:
- Acute onset of respiratory symptoms
- Bilateral pulmonary opacities on chest imaging
- Respiratory failure not fully explained by cardiac failure or fluid overload
- Appropriate ventilatory support requirements
The P/F ratio therefore provides an objective marker of oxygenation impairment and contributes directly to disease classification, prognosis, and therapeutic decision-making.
Clinical Assessment
Although highly valuable, the P/F ratio represents only one component of respiratory assessment. Accurate interpretation requires consideration of the patient’s overall physiological status and should include evaluation of:
- Respiratory rate
- Work of breathing
- Oxygen saturation (SpO₂)
- Arterial blood gas analysis
- Fraction of inspired oxygen (FiO₂)
- Ventilator settings where applicable
- Chest imaging
- Haemodynamic status
- Underlying diagnosis
Clinical deterioration or improvement should be assessed using serial observations rather than isolated measurements alone.
Limitations
Several factors may influence interpretation of the P/F ratio.
Accurate calculation depends upon:
- Reliable arterial blood gas sampling
- Correct estimation or measurement of FiO₂
- Stable oxygen delivery
- Appropriate interpretation within the patient’s clinical context
The ratio may be affected by changes in ventilator settings, positive end-expiratory pressure (PEEP), patient positioning, and rapidly changing respiratory physiology. Consequently, the P/F ratio should not be used in isolation when assessing respiratory failure.
PaO₂/FiO₂ Ratio in Clinical Practice
The P/F ratio forms part of routine assessment in emergency departments, respiratory units, operating theatres, and intensive care units. It assists clinicians in determining the severity of hypoxaemia, monitoring response to oxygen therapy and ventilatory support, guiding escalation of treatment, and supporting evidence-based management of patients with acute respiratory failure.
Clinical Significance
The PaO₂/FiO₂ ratio remains one of the most valuable objective measures of pulmonary oxygenation in modern medicine. Its simplicity, reproducibility, and incorporation into internationally recognised diagnostic criteria make it an essential tool for evaluating respiratory function. When interpreted alongside comprehensive clinical assessment, imaging, laboratory investigations, and validated clinical guidelines, the P/F ratio provides critical information that supports diagnosis, prognostication, monitoring, and management of patients with respiratory compromise.